Novartis has agreed to pay $85 a share for Medicines Company in a deal that could be reached this weekend, according to The Wall Street Journal.
Novartis has agreed to pay $85 a share for Medicines Company in a deal that could be reached this weekend, according to The Journal.
The deal would strengthen the Swiss pharma giant's position in the market for heart treatments, The Journal reported. Novartis, which has a market value of over $200 billion, is already targeting that market with drugs such as the heart-failure treatment Entresto. However, Entresto's early sales have not met Wall Street's expectations, according to The Journal, though prescriptions have picked up with sales jumping to $430 million in the third quarter.
Medicines closed down nearly 2% Friday at 68.55 a share. The company, which has a market cap of about $5.4 billion, is up 258% year to date.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Exclusive: Unilever, Henkel and buyout funds eye bids for Coty's $7 billion beauty brands – sourcesConsumer goods giants Unilever and Henkel and a series of buyout funds including...
続きを読む »
PG&E Reportedly Nears $1.7 Billion California Wildfires SettlementIt’s the latest development in the PG&E saga.
続きを読む »
Chinese antitrust regulator approves Boeing-Embraer dealA Chinese antitrust regulator has approved Boeing Co's deal to buy a contro...
続きを読む »
John Sherman Buys Kansas City Royals For $1 BillionThe Kansas City Royals have been bought by Kansas City businessman and former Cleveland Indians minority owner John Sherman for $1 billion
続きを読む »
Adam Neumann's $1.7 billion golden parachute could be slashed as SoftBank looks to trim its WeWork rescue deal | Markets InsiderAdam Neumann's $1.7 billion golden parachute could be slashed as SoftBank bosses seek to trim the $9.5 billion rescue deal they struck with WeWo...
続きを読む »